These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8564522)

  • 1. The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A.
    Hartman DA; Ochalski SJ; Carlson RP
    Inflamm Res; 1995 Jul; 44(7):269-74. PubMed ID: 8564522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of anti-inflammatory and antiallergic drugs on the release of IL-1 beta and TNF-alpha in the human whole blood assay.
    Hartman DA; Ochalski SJ; Carlson RP
    Agents Actions; 1993; 39 Spec No():C70-2. PubMed ID: 8273590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rolipram in a murine model of acute inflammation: comparison with the corticoid dexamethasone.
    Klemm P; Harris HJ; Perretti M
    Eur J Pharmacol; 1995 Jul; 281(1):69-74. PubMed ID: 8566119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.
    Sekut L; Yarnall D; Stimpson SA; Noel LS; Bateman-Fite R; Clark RL; Brackeen MF; Menius JA; Connolly KM
    Clin Exp Immunol; 1995 Apr; 100(1):126-32. PubMed ID: 7697910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells.
    Yoshimura T; Kurita C; Nagao T; Usami E; Nakao T; Watanabe S; Kobayashi J; Yamazaki F; Tanaka H; Nagai H
    Gen Pharmacol; 1997 Oct; 29(4):633-8. PubMed ID: 9352314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases.
    Bruin KF; Hommes DW; Jansen J; Tytgat GN; Wouter ten Cate J; van Deventer SJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):791-5. PubMed ID: 7496871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor.
    Prabhakar U; Lipshutz D; Bartus JO; Slivjak MJ; Smith EF; Lee JC; Esser KM
    Int J Immunopharmacol; 1994 Oct; 16(10):805-16. PubMed ID: 7843852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial. Novel effects independent of inhibition of lipid mediator production.
    Glaser KB; Lock YW
    Biochem Pharmacol; 1995 Sep; 50(7):913-22. PubMed ID: 7575673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of Mannheimia haemolytica lipopolysaccharide and leukotoxin-induced cytokine expression in bovine alveolar macrophages.
    Malazdrewich C; Thumbikat P; Abrahamsen MS; Maheswaran SK
    Microb Pathog; 2004 Mar; 36(3):159-69. PubMed ID: 14726234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages.
    Kambayashi T; Jacob CO; Zhou D; Mazurek N; Fong M; Strassmann G
    J Immunol; 1995 Nov; 155(10):4909-16. PubMed ID: 7594495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo.
    Rice GC; Rosen J; Weeks R; Michnick J; Bursten S; Bianco JA; Singer JW
    Shock; 1994 Apr; 1(4):254-66. PubMed ID: 7735959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.
    Griswold DE; Webb EF; Breton J; White JR; Marshall PJ; Torphy TJ
    Inflammation; 1993 Jun; 17(3):333-44. PubMed ID: 7687237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.
    Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M
    J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram.
    Pettipher ER; Labasi JM; Salter ED; Stam EJ; Cheng JB; Griffiths RJ
    Br J Pharmacol; 1996 Apr; 117(7):1530-4. PubMed ID: 8730750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha production.
    Griswold DE; Hillegass LM; Breton JJ; Esser KM; Adams JL
    Drugs Exp Clin Res; 1993; 19(6):243-8. PubMed ID: 8013267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of human cytokine production and effects of pharmacological agents in a heterologous system in vivo.
    Griswold DE; Hillegass LM; O'Leary-Bartus J; Lee JC; Laydon JT; Torphy TJ
    J Immunol Methods; 1996 Sep; 195(1-2):1-5. PubMed ID: 8814313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopharmacological potential of selective phosphodiesterase inhibition. I. Differential regulation of lipopolysaccharide-mediated proinflammatory cytokine (interleukin-6 and tumor necrosis factor-alpha) biosynthesis in alveolar epithelial cells.
    Haddad JJ; Land SC; Tarnow-Mordi WO; Zembala M; Kowalczyk D; Lauterbach R
    J Pharmacol Exp Ther; 2002 Feb; 300(2):559-66. PubMed ID: 11805217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.